Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Choose Topic

Inflammatory dermatoses, infections and drug eruptions are the most common skin conditions in hospitalized cancer patients

Journal of the American Academy of Dermatology | Jan 02, 2018 Dermatologic Oncology General Oncology

Rituximab maintenance vs observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): An open-label, randomised phase 3 study

The Lancet Haematology | Jan 02, 2018 General Oncology Pharmacology/Therapy Leukemia/Lymphoma

A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial

European Journal of Cancer | Jan 01, 2018 Pharmacology/Therapy GI Oncology General Oncology

Momelotinib vs best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): A randomised, open-label, phase 3 trial

The Lancet Haematology | Jan 01, 2018 Pharmacology/Therapy Myeloproliferative Dz General Oncology

Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma

Virchows Archiv | Dec 31, 2017 Gynecologic Oncology General Oncology

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis

Clinical Rheumatology | Dec 30, 2017 BMT/SCT General Oncology

HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas

Histopathology | Dec 27, 2017 Head and Neck General Oncology

Randomized phase III trial of adjuvant pazopanib vs placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma

Journal of Clinical Oncology | Dec 22, 2017 Renal/Urologic Pharmacology/Therapy General Oncology

Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1–positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 Study

Journal of Clinical Oncology | Dec 22, 2017 Head and Neck General Oncology

Phase III, randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor–positive metastatic breast cancer: ALTERNATIVE

Journal of Clinical Oncology | Dec 22, 2017 General Oncology Breast Pharmacology/Therapy

« Prev 1 … 1113 1114 1115 1116 1117 … 1255 Next »

Inflammatory dermatoses, infections and drug eruptions are the most common skin conditions in hospitalized cancer patients

Rituximab maintenance vs observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): An open-label, randomised phase 3 study

A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial

Momelotinib vs best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): A randomised, open-label, phase 3 trial

Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis

HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas

Randomized phase III trial of adjuvant pazopanib vs placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma

Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1–positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 Study

Phase III, randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor–positive metastatic breast cancer: ALTERNATIVE

Managing Chronic Kidney Disease

Polycystic Ovary Syndrome: Management Strategies

Fibrate Therapy: Understanding the Risks

Anaesthetic Management in Obese Patients

Lasers: A Boon in Paediatric Dentistry

Inflammatory dermatoses, infections and drug eruptions are the most common skin conditions in hospitalized cancer patients

Rituximab maintenance vs observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): An open-label, randomised phase 3 study

A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial

Momelotinib vs best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): A randomised, open-label, phase 3 trial

Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis

HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas

Randomized phase III trial of adjuvant pazopanib vs placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma

Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1–positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 Study

Phase III, randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor–positive metastatic breast cancer: ALTERNATIVE

Managing Chronic Kidney Disease

Polycystic Ovary Syndrome: Management Strategies

Fibrate Therapy: Understanding the Risks

Anaesthetic Management in Obese Patients

Lasers: A Boon in Paediatric Dentistry

Select Specialty

Select Topic